Developing targeted therapies for Ewing sarcoma
Official title: Targeting EWSR1-FLI1 through Functional, Structural and Chemical Approaches
Funded at Ut Southwestern Medical Center · NIH-9834547 · Data updated 2026-11-12
This study is working on new treatments for Ewing sarcoma, a cancer that mainly affects kids and teens, by finding ways to target a specific protein that helps the cancer grow, so that we can offer safer and better options for those fighting this disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | September 16, 2019 |
| Project end | August 31, 2025 |
| Funding year | 2019 |
| Award (this year) | $10,042,149 |
| NIH project number | 1U54CA231649-01A1 |
| Project ID | NIH-9834547 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children and adolescents diagnosed with Ewing sarcoma, particularly those with metastatic disease.
✕Less likely to help
Patients with other types of cancer or those who do not have Ewing sarcoma may not benefit from this research.
What this research studies
This research focuses on Ewing sarcoma, a type of cancer that primarily affects children and adolescents. It aims to create effective therapies that specifically target the EWSR1-FLI1 fusion protein, which is unique to Ewing sarcoma cells. The approach involves overcoming current challenges in developing these therapies, including the lack of reliable models for testing and the perception that certain proteins are difficult to target with drugs. By addressing these issues, the research seeks to provide safer and more effective treatment options for patients.
Why it matters
Potential benefit: If successful, this research could lead to more effective and less toxic treatments for Ewing sarcoma patients.
How similar studies have gone: While targeted therapies for Ewing sarcoma are still in development, similar approaches in targeting specific cancer proteins have shown promise in other malignancies.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Mcfadden, David Glenn — Ut Southwestern Medical Center
- Study coordinator: Mcfadden, David Glenn
Related research
Other NIH-funded projects on the same topics.
-
Neural roots of how autistic adults understand word meaning
A study to understand how adults with autism process word meanings in the brain, aiming to improve language support.
-
A new approach to healing NF1-related tibia fractures in children
This grant aims to understand why some NF1-related leg fractures in kids don’t heal well and to develop better treatments to help them recover without complications.
-
Multi-center study on how ventilation during CPR relates to cardiac arrest outcomes
A large, real-world study will look at how ventilation during CPR affects survival after out-of-hospital cardiac arrest in adults.
-
National Spina Bifida Patient Registry across the U.S.
A national registry collects health information from people with spina bifida to help doctors and families get better, more consistent care.
-
MONA-LISA: Understanding Why Autoimmune Signals Turn into Lupus Over Time
A study using data and samples from people with early autoimmune signs to understand why some develop full-blown lupus and others do not.
-
Understanding why some people with herpes virus encephalitis get sick more badly
We’re studying why certain people, including kids and adults, develop severe brain inflammation from herpes simplex virus and whether genetic or immune factors explain why vaccines don’t prevent it yet.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.